FDA Inspection
Revive Rx LLC dba Revive Rx PharmacyRevive Rx LLC dba Revive Rx Pharmacy – FDA Inspection, Mar 27, 2026
Record Details
This FDA Inspection record concerns Revive Rx LLC dba Revive Rx Pharmacy, with an inspection on March 27, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · faa0dece-c864-4ebc-b255-3a5e10ce13fb
Inspection Facts
- Inspection number
- 1305262
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- FDCA 501(a)(2)(A)Exposed to lower quality air/ISO 5
- FDCA 501(a)(2)(A)Inadequate smoke studies
- FDCA 501(a)(2)(A)Lack of, personnel sampling
- FDCA 501(a)(2)(A)Lyophilizers, inadequately or not sterilized
- FDCA 501(a)(2)(A)Microbial contamination was present, ISO 5/areas adjacent
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Revive Rx LLC dba Revive Rx Pharmacy
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | OAI | Dallas District Office | Drug Quality Assurance |
| May 4, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 6, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Revive Rx LLC dba Revive Rx Pharmacy
- FDA Inspection 1261213 - 2025-02-07
- FDA Inspection 1168666 - 2022-05-04
- FDA Inspection 1149791 - 2021-08-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.